Ausbil Investment Management Ltd Decreases Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Ausbil Investment Management Ltd trimmed its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 83.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,193 shares of the medical instruments supplier's stock after selling 11,053 shares during the quarter. Ausbil Investment Management Ltd's holdings in LeMaitre Vascular were worth $201,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in LMAT. AQR Capital Management LLC raised its position in shares of LeMaitre Vascular by 68.6% during the 2nd quarter. AQR Capital Management LLC now owns 22,569 shares of the medical instruments supplier's stock worth $1,857,000 after purchasing an additional 9,183 shares during the last quarter. The Manufacturers Life Insurance Company lifted its holdings in LeMaitre Vascular by 5.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 10,469 shares of the medical instruments supplier's stock valued at $861,000 after purchasing an additional 583 shares in the last quarter. Truist Financial Corp raised its position in shares of LeMaitre Vascular by 92.1% in the second quarter. Truist Financial Corp now owns 7,054 shares of the medical instruments supplier's stock valued at $580,000 after buying an additional 3,381 shares during the last quarter. GAMMA Investing LLC boosted its position in LeMaitre Vascular by 34.3% during the third quarter. GAMMA Investing LLC now owns 736 shares of the medical instruments supplier's stock worth $68,000 after acquiring an additional 188 shares during the last quarter. Finally, USA Financial Formulas purchased a new stake in LeMaitre Vascular during the 3rd quarter valued at about $60,000. 84.64% of the stock is currently owned by institutional investors and hedge funds.

LeMaitre Vascular Trading Up 2.6 %

LMAT traded up $2.52 on Tuesday, hitting $97.95. 89,072 shares of the company were exchanged, compared to its average volume of 145,295. The firm has a 50-day moving average price of $97.41 and a two-hundred day moving average price of $92.94. LeMaitre Vascular, Inc. has a twelve month low of $57.60 and a twelve month high of $109.58. The company has a market cap of $2.20 billion, a price-to-earnings ratio of 53.45, a price-to-earnings-growth ratio of 2.13 and a beta of 0.96.

Wall Street Analyst Weigh In

LMAT has been the subject of a number of analyst reports. Barrington Research upped their price target on LeMaitre Vascular from $92.00 to $93.00 and gave the company an "outperform" rating in a research report on Friday, November 1st. Oppenheimer reiterated an "outperform" rating and issued a $93.00 target price (up from $90.00) on shares of LeMaitre Vascular in a report on Friday, November 1st. Cantor Fitzgerald initiated coverage on LeMaitre Vascular in a report on Tuesday, October 15th. They issued a "neutral" rating and a $96.00 price objective on the stock. Finally, StockNews.com downgraded LeMaitre Vascular from a "buy" rating to a "hold" rating in a research report on Friday, December 13th. Three equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $94.57.

Insider Activity at LeMaitre Vascular

In other LeMaitre Vascular news, Director Bridget A. Ross sold 3,750 shares of LeMaitre Vascular stock in a transaction that occurred on Friday, November 15th. The stock was sold at an average price of $101.47, for a total transaction of $380,512.50. Following the transaction, the director now owns 2,278 shares of the company's stock, valued at $231,148.66. The trade was a 62.21 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 10.79% of the stock is currently owned by corporate insiders.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.